Delivery Order SPE2DX22D0099-SPE2D825FAP2F
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $114,132.07 to AmerisourceBergen Drug Corp on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,094.70 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,684.19 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $386,479.07 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price, non-set-aside contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,394.30 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,446.79 to AmerisourceBergen Drug Corp on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,392.44 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $738,830.10 to AmerisourceBergen Drug Corp on September 6, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price delivery order, which is not set-aside, leverages AmerisourceBergen's position as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,367.28 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract issued to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,090 to AmerisourceBergen Drug Corp on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D825FAP2FDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $136,175.07 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply delivery. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform services at its corporate office location. The delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a diverse range of medical products to federal healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's delivery orders under the SPE2DX IDC support military healthcare programs and serve customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies AmerisourceBergen Drug Corp's capability to fulfill federal medical procurement requirements through open competition, consistent with the Defense Logistics Agency's strategy to maintain multiple vendor relationships for pharmaceutical prime vendor programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $136.2k | 7/14/25 |